Benzinga··Vandana SinghSupreme Court Blocks Eli Lilly Appeal in $194M Medicaid Fraud Case
Supreme Court rejects Eli Lilly's appeal, upholding $194M whistleblower judgment in Medicaid fraud case. Stock fell 1.64%.
LLYSupreme Courtwhistleblower
pharmaceutical pricing
3 articlesBenzinga··Vandana Singh
Benzinga··Vandana SinghRegeneron Strikes Landmark Deal With Trump Administration on Drug Pricing
Regeneron agrees with Trump Administration to lower drug prices via Medicaid benchmarking and free gene therapy access, receiving three years of tariff relief and regulatory certainty.
REGNFDA approvalgene therapy
Benzinga··Tanya RawatTrump Administration Threatens 100% Tariffs on Non-Compliant Drugmakers
Trump administration preparing 100% tariffs on pharmaceutical companies refusing pricing deals, with major drugmakers already securing three-year reprieves through MFN agreements.
AMGNJNJPFELLYNVO+3tariffshealthcare affordability